Cargando…
Inhibitor in Congenital Factor VII Deficiency; a Rare but Serious Therapeutic Challenge—A Systematic Literature Review
Background: Congenital factor (F) VII deficiency is a rare coagulation factor deficiency with an estimated incidence of 1 per 500,000 individuals. Patients with severe FVII deficiency present a broad range of clinical presentations. Alloimmunization against exogenous FVII, as the main challenge of r...
Autores principales: | Ramezanpour, Nahid, Zaker, Farhad, Biswas, Arijit, Dorgalaleh, Akbar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827513/ https://www.ncbi.nlm.nih.gov/pubmed/33435610 http://dx.doi.org/10.3390/jcm10020211 |
Ejemplares similares
-
How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency
por: Shahraki, Hojat, et al.
Publicado: (2020) -
The Relationship between Inflammatory Cytokines and Coagulopathy in Patients with COVID-19
por: Rad, Fariba, et al.
Publicado: (2021) -
Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency
por: Rajpurkar, Madhvi, et al.
Publicado: (2018) -
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013) -
Hemophagocytic lymphohistiocytosis and congenital factor VII deficiency: a case report
por: Wang, Xiong, et al.
Publicado: (2018)